Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

1. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002768

2. Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

   Qamar Abuhassan, Ghaleb Oriquat, R. Roopashree +5

   МақолаInflammasome and immune disordersTissue and Cell20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002974